Crescent Biopharma

CBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$603.589 M

$16.25 -3.79%

Close of 21 Sept 2026

Revenue

$10.8M

#3143 by revenue

Earnings

$153.9K

#2436 by earnings

Shares outstanding

37,143,940

Latest filing cover page

P/E ratio

3920.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#191Shattuck LabsSTTK$613.2M
#192CorMedixCRMD$605.6M
#193Crescent BiopharmaCBIO$603.6M
#194Phathom PharmaceuticalsPHAT$602.7M
#195CytomX TherapeuticsCTMX$601.4M

What if Crescent Biopharma were worth as much as…

Open the what-if tool →

Gold $30.3T

$815,046.93

Per share 50,157× higher

Bitcoin $1.72T

$46,301.06

Per share 2,849× higher

Nvidia $5.48T

$147,530.34

Per share 9,079× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Crescent Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.